EcoR1 Capital LLC 13D and 13G filings for ORIC Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:54 pm Sale |
2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital LLC | 3,418,068 4.900% |
-2,857,142 (-45.53%) |
Filing |
| 2024-02-14 6:19 pm Purchase |
2023-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital LLC | 6,275,210 8.900% |
2,857,142 (+83.59%) |
Filing |
| 2023-02-10 1:56 pm Sale |
2022-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital LLC | 3,418,068 7.600% |
-50,876 (-1.47%) |
Filing |
| 2022-02-14 3:02 pm Purchase |
2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital LLC | 3,468,944 8.800% |
376,726 (+12.18%) |
Filing |
| 2021-02-16 12:07 pm Purchase |
2020-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital LLC | 3,092,218 8.700% |
450,000 (+17.03%) |
Filing |
| 2020-05-01 5:29 pm Purchase |
2020-04-24 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital LLC | 2,642,218 8.800% |
2,642,218 (New Position) |
Filing |